Home    Back

Bleomycin baxter    (DrugBank: Bleomycin)

4 diseases
IDDisease name (Link within this page)Number of trials
96Crohn disease0
278Huge lymphatic malformation with cervicofacial lesion0
279Huge venous malformation with cervical, oral and pharyngeal diffuse lesion1
280Huge arteriovenous malformation with cervicofacial or limb lesion0

96. Crohn disease    [ 2,209 clinical trials,   1,276 drugs,   (DrugBank: 240 drugs),   166 drug target genes,   210 drug target pathways]
Searched query = "Crohn disease", "Terminal ileitis"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: . Trials are sorted by Date_enrollment from most recent to oldest in the table.
0 / 2,209 trial found

278. Huge lymphatic malformation with cervicofacial lesion    [ 19 clinical trials,   23 drugs,   (DrugBank: 7 drugs),   5 drug target genes,   62 drug target pathways]
Searched query = "Huge lymphatic malformation with cervicofacial lesion", "Huge lymphatic malformation", "Lymphatic malformation"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: . Trials are sorted by Date_enrollment from most recent to oldest in the table.
0 / 19 trial found

279. Huge venous malformation with cervical, oral and pharyngeal diffuse lesion    [ 12 clinical trials,   23 drugs,   (DrugBank: 9 drugs),   3 drug target genes,   103 drug target pathways]
Searched query = "Huge venous malformation with cervical, oral and pharyngeal diffuse lesion", "Huge venous malformation", "Venous malformation"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: 03/15/2021. Trials are sorted by Date_enrollment from most recent to oldest in the table.
1 / 12 trial found
No.TrialIDDate_
enrollment		Date_
registration		Public_titleScientific_titleConditionInterventionPrimary_
sponsor		Secondary_
sponsor		Recruitment_
Status		Inclusion_
agemin		Inclusion_
agemax		Inclusion_
gender		Target_
size		PhaseCountries
1EUCTR2011-001455-37-NO
(EUCTR)		21/12/201101/06/2011Prospective randomized interventional study in patients with venous malformations.Prospective randomized interventional study. Compare the effect of bleomycin and Tetradecyl Sodium Sulphate (Fibrovein) in the treatment of venous malformations. Clinical neurological and neurophysiological study of a subpopulation of patients with venous malformations. Venous malformation
MedDRA version: 13.1;Level: LLT;Classification code 10047229;Term: Venous malformation NOS;System Organ Class: 10010331 - Congenital, familial and genetic disorders;Therapeutic area: Diseases [C] - Congenital, Hereditary, and Neonatal Diseases and Abnormalities [C16]		Trade Name: Bleomycin Baxter
Product Name: Bleomycin
Trade Name: Fibrovein 3%
Product Name: Fibrovein 3%		Department of Radiology, Oslo University Hospital, NorwayNULLAuthorised-recruitment may be ongoing or finishedFemale: yes
Male: yes		Norway

280. Huge arteriovenous malformation with cervicofacial or limb lesion    [ 22 clinical trials,   26 drugs,   (DrugBank: 13 drugs),   11 drug target genes,   147 drug target pathways]
Searched query = "Huge arteriovenous malformation with cervicofacial or limb lesion", "Huge arteriovenous malformation", "Arteriovenous malformation"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: . Trials are sorted by Date_enrollment from most recent to oldest in the table.
0 / 22 trial found